Interact to see
Advertisement
Advertisement
BBVLX vs VIVAX
BBVLX vs VIVAX Comparison
Open Charts BBVLX vs VIVAX
Bridge Builder Large Cap Value
Price$18.61
Change-$0.19 (-1.01%)
VolumeN/A
Net Assets25.23B
Vanguard Value Index I
Price$73.17
Change-$0.74 (-1.00%)
VolumeN/A
Net Assets207.95B
BBVLX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
BBVLX vs. VIVAX commentary
Nov 14, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBVLX is a Buy and VIVAX is a Buy.
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 208B vs. BBVLX (25.2B). VIVAX pays higher dividends than BBVLX: VIVAX (1.98) vs BBVLX (1.72). BBVLX was incepted earlier than VIVAX: BBVLX (11 years) vs VIVAX (33 years). BBVLX (0.46) is less costly to investors than VIVAX (0.17). BBVLX has a lower initial minimum investment than VIVAX: BBVLX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 6.68 vs. BBVLX (-0.31). VIVAX return over 5 years is better than : 66.34 vs. BBVLX (47.70).
| BBVLX | VIVAX | BBVLX / VIVAX | |
| Total Expense Ratio | 0.24 | 0.17 | 141% |
| Annual Report Gross Expense Ratio | 0.46 | 0.17 | 271% |
| Fund Existence | 11 years | 33 years | - |
| Gain YTD | 10.209 | 11.965 | 85% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 25.2B | 208B | 12% |
| Annual Yield % from dividends | 1.72 | 1.98 | 87% |
| Returns for 1 year | -0.31 | 6.68 | -5% |
| Returns for 3 years | 22.36 | 33.49 | 67% |
| Returns for 5 years | 47.70 | 66.34 | 72% |
| Returns for 10 years | 129.12 | 135.00 | 96% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 31.50 | 0.02 | +0.05% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| ECML | 32.19 | N/A | N/A |
| Euclidean Fundamental Value ETF | |||
| CPSN | 26.74 | -0.06 | -0.21% |
| Calamos S&P 500 Structured Alt Protection ETF - November | |||
| HYBL | 28.39 | -0.09 | -0.32% |
| State Street® Blackstone High Income ETF | |||
| EDV | 68.25 | -0.84 | -1.22% |
| Vanguard Extended Duration Trs ETF | |||